Search

everythinglearnresearchcommunity

for

Search:↓

People with severe hair loss (Alopecia Areata) have different scalp bacteria than healthy people, which might help predict the condition's progress.

PRP is a safe and effective treatment for limited alopecia areata.

People with autism are more likely to develop alopecia areata than those without autism.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Korean medicine may help with hair growth in alopecia, but more research is needed to confirm this.

Alopecia areata is unpredictable, with limited treatment effectiveness, especially in severe cases.

People with alopecia who are more resilient tend to feel less stressed.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

Both platelet-rich plasma and low-level laser therapy effectively treat hair loss with minimal side effects and good cost-benefit ratio.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Autoimmune myopathy may be linked to hair loss and skin depigmentation.

Eyelash regrowth occurred after eyelid surgery in a man with severe hair loss.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Men with alopecia often feel less confident and have lower wellbeing, needing more support.

Topical tofacitinib is effective and safe for treating alopecia areata.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.